Regional Cancer Center ~ Erie, PA

Open Trials

Gastrointestinal

RTOG 0436 - A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are treated without surgery


Prostate

RTOG 0815 - A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short- Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer


Lung

ECOG 1505 - A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB-IIIA NSCLC

ECOG 5508 - Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevaciaumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced NSCLC

ACOSOG Z4099 - A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) vs. Stereotactic Body Radiation Therapy in High Risk Patients with Stage I NSCLC (Approval still Pending)


Head/Neck

RTOG 0920 A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head and Neck Cancer


Brain Metastases

RTOG 0933 A Phase II Trial of Hippocampal Avoidance during Whole Brain Radiotherapy for Brain Metastases


Breast

NSABP B 43 A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2+ Ductal Carcinoma In Situ Resected by Lumpectomy

CALGB 40601 Randomized Phase III Trial of Paclitaxel combined with Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment of Her2+ Primary Breast Cancer


Non-Therapeutic

Precision Therapuetic PT-207 Precision Therapeutic Registry Chemoresponse Assay in Solid Tumors


Diagnostic

ACRIN (American College of Radiology Imaging Network) NOPR Trial - Sodium Floride Bone Mets

ACRIN (American College of Radiology Imaging Network) NOPR Trial - The National Oncologic PET Registry—Center for Medicare and Medicaid Services to expand coverage for PET emission tomography to include cancer indications not currently covered

ProWebsite provided by newline Creations